M. G. Aman

1.2k total citations
32 papers, 872 citations indexed

About

M. G. Aman is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, M. G. Aman has authored 32 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 10 papers in Cognitive Neuroscience and 7 papers in Clinical Psychology. Recurrent topics in M. G. Aman's work include Attention Deficit Hyperactivity Disorder (16 papers), Autism Spectrum Disorder Research (9 papers) and Child and Adolescent Psychosocial and Emotional Development (5 papers). M. G. Aman is often cited by papers focused on Attention Deficit Hyperactivity Disorder (16 papers), Autism Spectrum Disorder Research (9 papers) and Child and Adolescent Psychosocial and Emotional Development (5 papers). M. G. Aman collaborates with scholars based in United States, New Zealand and Belgium. M. G. Aman's co-authors include Nirbhay N. Singh, Sabrina N. Grondhuis, Edwin A. Mitchell, John S. Werry, Anthony J. White, S Reiss, Glenn Richmond, Alistair W. Stewart, Christopher J. McDougle and Carolyn Field and has published in prestigious journals such as Biological Psychiatry, Journal of Chromatography A and Psychopharmacology.

In The Last Decade

M. G. Aman

32 papers receiving 799 citations

Peers

M. G. Aman
Morris Zwi United Kingdom
Mortimer D. Gross United States
Luuk J. Kalverdijk Netherlands
Lin Sikich United States
Vania Modesto‐Lowe United States
Anna M. Wehry United States
Linsey M. Utzinger United States
M. G. Aman
Citations per year, relative to M. G. Aman M. G. Aman (= 1×) peers Jovan Simeon

Countries citing papers authored by M. G. Aman

Since Specialization
Citations

This map shows the geographic impact of M. G. Aman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. G. Aman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. G. Aman more than expected).

Fields of papers citing papers by M. G. Aman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. G. Aman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. G. Aman. The network helps show where M. G. Aman may publish in the future.

Co-authorship network of co-authors of M. G. Aman

This figure shows the co-authorship network connecting the top 25 collaborators of M. G. Aman. A scholar is included among the top collaborators of M. G. Aman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. G. Aman. M. G. Aman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCracken, James T., David J. Posey, M. G. Aman, et al.. (2013). Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. The Pharmacogenomics Journal. 14(3). 295–302. 32 indexed citations
2.
Nurmi, Erika L., Fiona Whelan, M. G. Aman, et al.. (2013). Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. Translational Psychiatry. 3(6). e274–e274. 44 indexed citations
3.
Grondhuis, Sabrina N. & M. G. Aman. (2013). Overweight and obesity in youth with developmental disabilities: a call to action. Journal of Intellectual Disability Research. 58(9). 787–799. 63 indexed citations
4.
Aman, M. G., Lawrence David Scahill, Naomi B. Swiezy, et al.. (2010). The Home Situations Questionnaire‐PDD version: Factor structure and psychometric properties. Journal of Intellectual Disability Research. 54(3). 281–291. 29 indexed citations
5.
Flarakos, Jimmy, et al.. (2003). Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography–mass spectrometry. Journal of Chromatography A. 1026(1-2). 175–183. 41 indexed citations
6.
McDougle, Christopher J., M. G. Aman, James T. McCracken, et al.. (2003). P.2.109 A double-blind placebo-controlled trial of risperidone in autistic disorder. European Neuropsychopharmacology. 13. S327–S328. 2 indexed citations
7.
Findling, Robert L., M. G. Aman, Goedele De Smedt, & Albert Derivan. (2002). Risperidone in children with conduct problems and subaverage IQ. European Psychiatry. 17. 118–118. 1 indexed citations
8.
Turgay, Atilla, M. G. Aman, & Carin Binder. (2001). Risperidone in children with various disruptive behavior disorders, subaverage IQ and comorbid ADHD. European Neuropsychopharmacology. 11. S256–S256. 1 indexed citations
9.
Arnold, L. Eugene, M. G. Aman, Andrés Martin, et al.. (2000). Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network. Journal of Autism and Developmental Disorders. 30(2). 99–111. 91 indexed citations
10.
Aman, M. G., et al.. (2000). Pharmacotherapy of disorders in mental retardation. European Child & Adolescent Psychiatry. 9(S1). S98–S107. 23 indexed citations
11.
Reiss, S & M. G. Aman. (1997). The international consensus process on psychopharmacology and intellectual disability. Journal of Intellectual Disability Research. 41(6). 448–455. 33 indexed citations
12.
Aman, M. G.. (1996). Four-year follow-up of children with low intelligence and ADHD. Research in Developmental Disabilities. 17(6). 417–432. 35 indexed citations
13.
Aman, M. G.. (1990). Considerations in the use of psychotropic drugs in elderly mentally retarded persons. Journal of Intellectual Disability Research. 34(1). 1–10. 6 indexed citations
14.
Aman, M. G., et al.. (1989). Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.. PubMed. 93(4). 452–60. 41 indexed citations
15.
Aman, M. G., et al.. (1987). The aberrant behavior checklist: factor structure and the effect of subject variables in American and New Zealand facilities.. PubMed. 91(6). 570–8. 63 indexed citations
16.
Aman, M. G., et al.. (1987). Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions.. PubMed. 92(2). 237–40. 60 indexed citations
17.
Field, Carolyn, et al.. (1986). A SINGLE‐SUBJECT STUDY OF IMIPRAMINE IN A MENTALLY RETARDED WOMAN WITH DEPRESSIVE SYMPTOMS. Journal of Intellectual Disability Research. 30(2). 191–198. 19 indexed citations
18.
Aman, M. G., Anthony J. White, & Carolyn Field. (1984). CHLORPROMAZINE EFFECTS ON STEREOTYPIC AND CONDITIONED BEHAVIOUR OF SEVERELY RETARDED PATIENTS‐A PILOT STUDY. Journal of Intellectual Disability Research. 28(4). 253–260. 20 indexed citations
19.
Werry, John S., et al.. (1976). Haloperidol and methylphenidate in hyperactive children.. PubMed. 42(1). 26–40. 24 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026